Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 4

NCT04267458

Prevalence of Kidney Injury in Patients With HCV Treated With Sofuspovir Containing DAA Therapy

this study aims is to investigate the occurrence of AKI during antiviral therapy, defined as an increase of 0.3 mg/dL or 50% at least in serum creatinine level…

Egypt300 participantsStarted 2019-07-01

Treatment: evaluation of sofuspovir containing DAA regien expected insult on kidney